Holen Sie sich die Stockscreener-App
4.31
4.66%
0.21
Schlusskurs vom Vortag:
$4.10
Offen:
$4.05
24-Stunden-Volumen:
85,743
Relative Volume:
0.19
Marktkapitalisierung:
$31.07M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-29.96M
KGV:
-0.156
EPS:
-27.6253
Netto-Cashflow:
$-31.64M
1W Leistung:
+3.90%
1M Leistung:
+11.16%
6M Leistung:
-67.54%
1J Leistung:
+8.91%
1-Tages-Spanne:
$4.04
$4.31
1-Wochen-Bereich:
$3.94
$4.31
52-Wochen-Spanne:
$0.61
$14.68
Briacell Therapeutics Corp Stock (BCTX) Company Profile
Firmenname
Briacell Therapeutics Corp
Sektor
Branche
Telefon
(604) 921-1810
Adresse
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Compare BCTX vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BCTX
Briacell Therapeutics Corp
|
4.285 | 29.73M | 0 | -29.96M | -31.64M | -27.63 |
VRTX
Vertex Pharmaceuticals Inc
|
433.59 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
762.90 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
747.75 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.75 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
164.04 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-02-14 | Eingeleitet | H.C. Wainwright | Buy |
Briacell Therapeutics Corp Aktie (BCTX) Neueste Nachrichten
BCTX SEC FilingsBriacell Therapeutics Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Sentiment Recap: What is BriaCell Therapeutics Corp Equity Warrants valuation compared to sectorRecession Risk & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Technical Analysis: Does BriaCell Therapeutics Corp stock have upside surprise potentialQuarterly Portfolio Review & Risk Managed Investment Entry Signals - baoquankhu1.vn
Published on: 2026-04-01 12:14:35 - baoquankhu1.vn
BriaCell Therapeutics Reports Rising Losses and Funding Pressure - TipRanks
BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License - Investing News Network
Earnings Recap: Will BriaCell Therapeutics Corp Equity Warrant stock hit new highs in YEAR2026 Review & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
BriaCell Therapeutics files interim financial statements for subsidiary By Investing.com - Investing.com India
BriaCell transfers cancer immunotherapy asset to BriaPro in USD$1.18 million deal - Mugglehead Investment Magazine
BriaCell Therapeutics files interim financial statements for subsidiary - Investing.com
BriaCell subsidiary BriaPro posts $472k net loss, $1.61M related-party debt and closes sCD80 license deal - TradingView
BriaCell (NASDAQ: BCTX) unit adds sCD80 license, $3M credit lifeline - Stock Titan
BCTX Forecast, Price Target & Analyst Ratings | BRIACELL THERAPEUTICS CORP (NASDAQ:BCTX) - ChartMill
BriaCell Therapeutics Nears Critical Data Readout Following Trial Completion - AD HOC NEWS
Profit Recap: Can BriaCell Therapeutics Corp Equity Warrant continue delivering strong returnsPortfolio Update Summary & AI Based Trade Execution Alerts - baoquankhu1.vn
Aug Opening: Why is BriaCell Therapeutics Corp stock going down2026 Earnings & Real-Time Buy Signal Alerts - baoquankhu1.vn
Buybacks Report: Does BriaCell Therapeutics Corp have a sustainable dividend2026 Action & Accurate Intraday Trade Tips - baoquankhu1.vn
Momentum Shift: What is BriaCell Therapeutics Corp Equity Warrants valuation compared to sector2026 Weekly Recap & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Earnings Report: Should I set a stop loss on BriaCell Therapeutics Corp Equity Warrant2026 Sector Moves & Daily Volume Surge Trade Alerts - baoquankhu1.vn
If You Invested $1,000 in Briacell Therapeutics Corp (BCTX) - Stock Titan
BriaCell Therapeutics Corp.: Fundamental Analysis and Financial Ratings | | CA1079303071 - marketscreener.com
Earnings Beat: Can BriaCell Therapeutics Corp Equity Warrant continue delivering strong returnsDollar Strength & Reliable Intraday Trade Plans - baoquankhu1.vn
Dip Buying: Is now the right time to enter BriaCell Therapeutics Corp Equity Warrant2026 Highlights & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Portfolio Recap: Is BriaCell Therapeutics Corp a strong candidate for buy and hold2026 Chart Watch & Accurate Intraday Trade Tips - baoquankhu1.vn
Aug Catalysts: What is BriaCell Therapeutics Corp Equity Warrants debt to equity ratio2026 Fundamental Recap & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Travel Stocks: What is the next catalyst for CRNTProduct Launch & Low Risk High Reward Trade Ideas - baoquankhu1.vn
Treasury Yields: Can BriaCell Therapeutics Corp Equity Warrant continue delivering strong returns2026 Macro Impact & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Aug Outlook: Is BriaCell Therapeutics Corp Equity Warrant benefiting from innovation trends2026 Sentiment & Smart Allocation Stock Tips - baoquankhu1.vn
BCTX PE Ratio & Valuation, Is BCTX Overvalued - Intellectia AI
BriaCell (BCTX) to Reveal Key Findings at 2026 AACR Annual Meeti - GuruFocus
BriaCell to Spotlight Phase 3 Bria-IMT Data and Next-Gen Bria-OTS+ Platform at 2026 AACR - TipRanks
BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference - The Manila Times
BriaCell to Present Positive Clinical Data for Bria-IMT and Preclinical Data for Next Generation Bria-OTS+ Personalized Immunotherapy at the 2026 AACR Conference - Bitget
BriaCell to Present Positive Clinical Data for Bria-IMT™ - GlobeNewswire
(BCT) Strategic Investment Guide (BCT:CA) - Stock Traders Daily
BriaCell Therapeutics Corp. 2026 Q2 Financial Results and Nasdaq Listing Overview - Minichart
Published on: 2026-03-12 08:04:05 - baoquankhu1.vn
Take Profit: Is BriaCell Therapeutics Corp Equity Warrant benefiting from innovation trends2026 Buyback Activity & Daily Entry Point Trade Alerts - baoquankhu1.vn
Why did BCTX stock surge 50% today? - MSN
BriaCell (NASDAQ: BCTX) boosts cash to fund cancer trials amid higher losses - Stock Titan
BriaCell Therapeutics Corp. Files Form 8-K: Company Details, NASDAQ Ticker Symbols, and Key Disclosures (March 2026) 343637 - Minichart
BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting - Yahoo Finance
BriaCell Shareholders Approve Auditors and Reelect Board - TipRanks
BriaCell (NASDAQ: BCTX) shareholders re-approve equity plan and board slate - Stock Titan
Why retail investors favor BriaCell Therapeutics Corp. stock2026 Earnings Impact & Real-Time Chart Pattern Alerts - Naître et grandir
IPO Launch: How does BriaCell Therapeutics Corp Equity Warrant compare to its peersWeekly Stock Analysis & High Accuracy Trade Signal Alerts - baoquankhu1.vn
What sentiment indicators say about BriaCell Therapeutics Corp. Equity Warrant stock2025 Price Action Summary & Free High Return Stock Watch Alerts - Naître et grandir
Market Pulse: What is the next catalyst for BriaCell Therapeutics Corp2025 Bull vs Bear & Precise Buy Zone Identification - baoquankhu1.vn
Why is BriaCell Therapeutics Corp stock going downQuarterly Growth Report & Short-Term High Return Ideas - baoquankhu1.vn
Merger Talk: How does BriaCell Therapeutics Corp Equity Warrant compare to its peersWeekly Volume Report & Weekly Momentum Stock Picks - baoquankhu1.vn
How To Trade (BCT) (BCT:CA) - Stock Traders Daily
Finanzdaten der Briacell Therapeutics Corp-Aktie (BCTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.90%
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):